ISRCTN48486094已完成未知
REducing Deaths due to OXidative Stress: a randomised trial of glutamine and anti-oxidant supplementation in critically ill patients
Queen's University (Canada)0 个研究点目标入组 1,200 人开始时间: 2006年12月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Mechanically ventilated adult patients (more than or equal to 18 years old, either sex) admitted to ICU
- •2. Two or more of the following organ failures related to their acute illness:
- •2.1. A Partial Pressure of Oxygen in Arterial Blood (PaO2)/Fraction of Inspired Oxygen (FiO2) ratio of less than or equal to 300
- •2.2. Clinical evidence of hypoperfusion defined as the need for vasopressor agents (norepinephrine, epinephrine, vasopressin, more than or equal to 5 µg/kg/min of dopamine, or more than or equal to 50 µg/min phenylephrine) for greater than or equal to two hours
- •2.3. In patients without known renal disease, renal dysfunction defined as a serum creatinine more than or equal to 171 µmol/L or a urine output of less than 500 ml/last 24 hours (or 80 ml/last four hours if a 24 hour period of observation not available). In patients with acute on chronic renal failure (pre-dialysis), an absolute increase of more than or equal to 80 µmol/L from baseline or pre-admission creatinine or a urine output of less than 500 ml/last 24 hours (or 80 ml/last four hours) will be required
- •2.4. A platelet count of less than 50 x 10^9/
排除标准
- •1. More than 24 hours from admission to ICU
- •2. Patients who are moribund (not expected to be in ICU for more than 48 hours due to imminent death)
- •3. A lack of commitment to full aggressive care (anticipated withholding or withdrawing treatments in the first week)
- •4. Absolute contraindication to enteral nutrients (e.g., Gastro-Intestinal (GI) perforation, obstruction or no GI tract access for any reason)
- •5. Patients with severe acquired brain injury:
- •5.1. Significant head trauma (defined as an injury, in the opinion of the investigator, that represents a severe, disabling, or fatal brain injury)
- •5.2. Grade four or five subarachnoid haemorrhage
- •5.3. Stroke resulting in coma and intubation
- •5.4. Post-cardiac arrest with suspected significant anoxic brain injury
- •6. Seizure disorder requiring anticonvulsant medication
- •7. Cirrhosis - Child's class C liver disease
- •8. Metastatic cancer or Stage IV Lymphoma with life expectancy less than six months
- •9. Routine elective cardiac surgery (patients with complicated peri-operative course requiring pressors, Intra-Aortic Balloon Pump (IABP), ventricular assist devices can be included)
- •10. Patients with primary admission diagnosis of burns (more than or equal to 30% Body Surface Area [BSA])
- •11. Weight less than 50 kg or greater than 200 kg
- •12. Pregnant patients or lactating with the intent to breastfeed
- •13. Previous randomisation in this study
- •14. Enrolment in a related ICU interventional study
研究者
相似试验
进行中(未招募)
不适用
REducing Deaths due to OXidative Stress The REDOXS© Study A 2×2 factorial randomized trial of glutamine and antioxidant supplementation in critically ill patients - REDOXS©EUCTR2007-001831-73-DEKingston General Hospital, Queen's University of Kingston1,200
已完成
1 期
Control Body Tumor Microenvironment by Amelioration of Chronic Stress with Chinese Medicine of of Sanhuang Decoction (SHD) During Endocrine Treatment in Breast Cancer PatientsBreast cancerITMCTR2000004194Affiliated Hospital of Nanjing University of Traditional Chinese Medicine
已完成
不适用
Trial of Glutamine and Antioxidant Supplementation in Critically Ill PatientsCritical IllnessMultiple Organ FailureSepsisNCT00133978Daren K. Heyland1,223
招募中
3 期
Preventing Oxidative stress-induced ischemic injury and systemic inflammation complications during and after invasive cardiac surgery with Alkaline Phosphatase (APPIRED III)renal failureNL-OMON49105Alloksys Life Sciences BV150
进行中(未招募)
1 期
Preventing Systemic Inflammation after Cardiac surgery with Alkaline Phosphatase (APPIRED III)systemic inflammation as side-effect of heart-lung machine during cardiac surgeryMedDRA version: 20.0 Level: LLT Classification code 10017501 Term: Functional disturbances following cardiac surgery System Organ Class: 100000004863EUCTR2016-002663-33-BEAlloksys Life Sciences BV1,250
